Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
This study has been completed.
National Cancer Center, Korea
Information provided by (Responsible Party):
Ji-youn Han, National Cancer Center, Korea
First received: March 26, 2007
Last updated: September 15, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2011|
|Primary Completion Date:||February 2011 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Han JY, Kim JY, Lee SH, Yoo NJ, Choi BG. Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer. Lung Cancer. 2011 Nov;74(2):293-9. doi: 10.1016/j.lungcan.2011.02.021.